118 completed, 7 unknown, 4 terminated, 2 recruiting. 132 Phase 3, 19 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 132 | Completed 118, Unknown 7, Terminated 4, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 19 | Completed 17, Unknown 2 |
Follow Healthy: new trials by email Literature Review of Healthy trials Research Report on Healthy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies Multivalent Group B streptococcus vaccine, Placebo, Infanrix hexa - Healthy | Phase 3 | Recruiting | Pfizer | 6000 | 2025-08-25 | 2026-10-27 |
| A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1) V181, Placebo - Healthy | Phase 3 | Active not recruiting | Merck Sharp & Dohme LLC | 12000 | 2025-06-11 | 2026-11-10 |
| PK, PD, Safety and Immunogenicity Study of Erythropoietin of Incepta Pharmaceuticals Ltd With Eprex (Janssen-Cilag). Erythropoietin alfa - Healthy | Phase 3 | Completed | Incepta Pharmaceuticals Ltd | 56 | 2025-04-24 | 2026-11-05 |
| Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Infants IL-YANG FLU Vaccine Prefilled Syringe INJ., Fluarix Tetra Pre-filled Syringe - Healthy | Phase 3 | Completed | Il-Yang Pharm. Co., Ltd. | 260 | 2024-10-23 | 2026-07-08 |
| Hyaluronidase Assisted Subcutaneous Infusion hyaluronidase, Placebo - Healthy | Phase 3 | Completed | Shanghai Bao Pharmaceuticals Co., Ltd. | 45 | 2024-03-28 | 2024-09-23 |
| Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area Polyene Phosphatidylcholine, Matching placebo of AYP-101 - Healthy | Phase 3 | Completed | AMIpharm Co., Ltd. | 252 | 2024-03-26 | 2026-01-22 |
| Remimazolam Versus Midaszolam for Sedation in Diagnostic Upper Gastrointestinal Endoscopy Remimazolam, Midazolam - Healthy | Phase 3 | Completed | Samsung Medical Center | 132 | 2023-04-05 | 2025-11-18 |
| Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine NDV-HXP-S 10μg, BNT162b2 30μg - Coronavirus Infections, Healthy | Phase 2 / Phase 3 | Completed | Butantan Institute | 4400 | 2023-02-28 | 2025-02-06 |
| A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics Saline, Exendin-9,39, Liraglutide - Healthy | Phase 3 | Completed | Adrian Vella | 21 | 2022-10-17 | 2026-10-28 |
| Effect of Mouthwash in Reducing the Symptoms Associated With Flu and Cold Viruses cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash - Healthy | Phase 3 | Completed | Colgate Palmolive | 150 | 2022-06-05 | 2026-10-07 |
| Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes Saline, Exendin-9,39, Saline + Intralipid/Heparin - Healthy, Type 2 Diabetes | Phase 3 | Completed | Adrian Vella | 23 | 2021-04-15 | 2023-12-26 |
| A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Secretion Exendin-9,39, Saline - Healthy | Phase 3 | Completed | Adrian Vella | 11 | 2021-03-04 | 2023-06-09 |
| The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans 0.4mU Insulin followed by withdrawal period followed by 0.8mU study, 0.8mU Insulin followed by withdrawal period followed by 0.4mU study - Healthy | Phase 3 | Completed | Adrian Vella | 12 | 2020-10-14 | 2022-06-21 |
| A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women Ad26.ZEBOV, MVA-BN-Filo - Healthy | Phase 3 | Completed | Janssen Vaccines & Prevention B.V. | 4031 | 2020-10-05 | 2025-02-03 |
| A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo - Healthy | Phase 3 | Completed | Janssen Vaccines & Prevention B.V. | 3900 | 2019-10-31 | 2024-07-31 |
| Effects of tDCS on Maximal Isometric Strength and Endurance Test of Trunk Extensors. Transcranial direct current stimulation (tDCS) - Healthy | Phase 2 / Phase 3 | Completed | Universidade Federal do Piauí | 20 | 2019-01-02 | 2021-05-03 |
| Acute Olanzapine and Lipid Response Olanzapine 10 milligram, Bromocriptine 5 milligram, Placebo oral tablet - Healthy | Phase 2 / Phase 3 | Unknown | University Health Network, Toronto | 15 | 2019-01-01 | 2019-12-03 |
| Effects of Iron Supplements on the Pharmacokinetics of MT-6548 MT-6548, Iron supplement A, Iron supplement B - Healthy | Phase 3 | Completed | Tanabe Pharma Corporation | 61 | 2018-08-27 | 2026-04-06 |
| Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects HRIG, HyperRAB, RabAvert - Healthy | Phase 2 / Phase 3 | Completed | Bio Products Laboratory | 162 | 2017-12-08 | 2020-02-25 |
| Investigating Gains in Neurocognition in an Intervention Trial of Exercise 150 Minutes Week, 225 Minutes Week, Stretch and Tone - Healthy, Cognitive Function 1, Social | Phase 3 | Completed | University of Pittsburgh | 648 | 2017-09-06 | 2024-06-14 |
Showing 20 of 132. Sign in to see all of them.
Influenza, Human (6) · Hepatitis B (3) · Motor Activity (3) · Behavior (2) · Cognitive Dysfunction (2) · Diabetes Mellitus, Type 2 (2) · Hemorrhagic Fever, Ebola (2) · Hepatitis (2) · Tetanus (2) · Acidosis (1) · Alzheimer Disease (1) · Breast Feeding (1) · Breast Neoplasms (1) · COVID-19 (1) · Cardiomegaly (1)
Infections (16) · Virus Diseases (12) · RNA Virus Infections (10) · Respiratory Tract Diseases (8) · Respiratory Tract Infections (8) · Behavior (7) · Pathological Conditions, Signs and Symptoms (7) · Mental Disorders (6) · Metabolic Diseases (6) · Nutritional and Metabolic Diseases (6) · Orthomyxoviridae Infections (6) · Nervous System Diseases (5) · Endocrine System Diseases (4) · Neurocognitive Disorders (4) · Bacterial Infections (3)
Lactic Acid (7) · Sodium Chloride (5) · FluMist (4) · Cetylpyridinium (2) · Docosahexaenoic Acids (2) · Engerix-B (2) · Ethanol (2) · Ethinyl Estradiol (2) · Fluid Therapy (2) · Gels (2) · Glucagon-Like Peptide 1 (2) · Hepatitis B Vaccines (2) · LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (2) · Levonorgestrel (2) · Norethindrone (2)
Sanofi (8) · MedImmune LLC (7) · Derming SRL (5) · Pfizer (5) · Adrian Vella (4) · Il-Yang Pharm. Co., Ltd. (3) · Janssen Vaccines & Prevention B.V. (3) · Merck Sharp & Dohme LLC (3) · PT Bio Farma (3) · Boehringer Ingelheim (2) · Dynavax Technologies Corporation (2) · Georgetown University (2) · Massachusetts General Hospital (2) · Nobelpharma (2) · Sanofi Pasteur, a Sanofi Company (2)
United States (49) · Brazil (14) · Germany (9) · South Korea (7) · Canada (6) · China (5) · Italy (5) · Indonesia (4) · Japan (4) · Spain (4) · Denmark (3) · Finland (3) · France (3) · Philippines (3) · Switzerland (3)
Jaderson Lima (7) · Adele Sparavigna, Doctor (5) · Robert Walker, MD (3) · Adrian Vella (2) · Adrian Vella, MD (2) · Ali Khamesipour (2) · Stephanie T Page, MD, PhD (2) · Takefumi Matuo, MD (2) · Agnes Floeel, MD (1)
PMID 34930928, PMID 12425704, PMID 15557412, PMID 17179457, PMID 18922615, PMID 19142106, PMID 19273881, PMID 19395948, PMID 19491388, PMID 19549740, PMID 19587338, PMID 19608747, PMID 19828715, PMID 20130094, PMID 20133465, PMID 20176858, PMID 20216564, PMID 20431391, PMID 20605091, PMID 20920070, PMID 21106918, PMID 21490142, PMID 21775560, PMID 21955649, PMID 22010053, PMID 22158670, PMID 22162538, PMID 22378736, PMID 22633793, PMID 22691430, PMID 22776216, PMID 23032160, PMID 23082222, PMID 23256143, PMID 23283500, PMID 23284983, PMID 23727002, PMID 23847319, PMID 23897332, PMID 24027184, PMID 24063608, PMID 24089418, PMID 24273483, PMID 24388695, PMID 24527713, PMID 24553693, PMID 25061716, PMID 25424792, PMID 25651444, PMID 25873721
R01DK126206 (3), 2008 (1), 2009 (1), 2015 (1), 2018 (1), K24DK065018 (1), P01DK068055 (1), R01AG013241 (1), R01AG037603 (1), R01AG053952 (1), R01AG060050 (1), R01HL064342 (1), R21HL092799 (1), U01AG014260 (1), U01AG014263 (1)